398 related articles for article (PubMed ID: 26700439)
1. Relationship of Circulating Anti-C3b and Anti-C1q IgG to Lupus Nephritis and Its Flare.
Birmingham DJ; Bitter JE; Ndukwe EG; Dials S; Gullo TR; Conroy S; Nagaraja HN; Rovin BH; Hebert LA
Clin J Am Soc Nephrol; 2016 Jan; 11(1):47-53. PubMed ID: 26700439
[TBL] [Abstract][Full Text] [Related]
2. [Significance of serum anti-Clq Ab in evaluation of lupus nephritis activity and its curative effects of pharmacotherapy on lupus nephritis].
Cai XY; Yang XY; Chen XH; Liang LQ; Guan MM; Qin SG; Fu JZ
Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(17):1436-9. PubMed ID: 15500738
[TBL] [Abstract][Full Text] [Related]
3. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
[TBL] [Abstract][Full Text] [Related]
4. Nonrenal and renal activity of systemic lupus erythematosus: a comparison of two anti-C1q and five anti-dsDNA assays and complement C3 and C4.
Julkunen H; Ekblom-Kullberg S; Miettinen A
Rheumatol Int; 2012 Aug; 32(8):2445-51. PubMed ID: 21706294
[TBL] [Abstract][Full Text] [Related]
5. C-reactive protein, immunoglobulin G and complement co-localize in renal immune deposits of proliferative lupus nephritis.
Sjöwall C; Olin AI; Skogh T; Wetterö J; Mörgelin M; Nived O; Sturfelt G; Bengtsson AA
Autoimmunity; 2013 May; 46(3):205-14. PubMed ID: 23331132
[TBL] [Abstract][Full Text] [Related]
6. Circulating anti-C3b IgG in lupus nephritis: A large cohort study.
Tao J; Song D; Liu XL; Yu F; Zhao MH
Clin Immunol; 2020 Aug; 217():108514. PubMed ID: 32565324
[TBL] [Abstract][Full Text] [Related]
7. Do circulating antibodies against C1q reflect the activity of lupus nephritis?
Smykał-Jankowiak K; Niemir ZI; Polcyn-Adamczak M
Pol Arch Med Wewn; 2011 Sep; 121(9):287-95. PubMed ID: 21860370
[TBL] [Abstract][Full Text] [Related]
8. Anti-C1q autoantibodies from active lupus nephritis patients could inhibit the clearance of apoptotic cells and complement classical pathway activation mediated by C1q in vitro.
Pang Y; Yang XW; Song Y; Yu F; Zhao MH
Immunobiology; 2014 Dec; 219(12):980-9. PubMed ID: 25092568
[TBL] [Abstract][Full Text] [Related]
9. Anti-C1q autoantibodies in lupus nephritis: prevalence and clinical significance.
Sinico RA; Radice A; Ikehata M; Giammarresi G; Corace C; Arrigo G; Bollini B; Li Vecchi M
Ann N Y Acad Sci; 2005 Jun; 1050():193-200. PubMed ID: 16014534
[TBL] [Abstract][Full Text] [Related]
10. High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis.
Trendelenburg M; Lopez-Trascasa M; Potlukova E; Moll S; Regenass S; Frémeaux-Bacchi V; Martinez-Ara J; Jancova E; Picazo ML; Honsova E; Tesar V; Sadallah S; Schifferli J
Nephrol Dial Transplant; 2006 Nov; 21(11):3115-21. PubMed ID: 16877491
[TBL] [Abstract][Full Text] [Related]
11. Detection of Anti-C3b Autoantibodies by ELISA.
Radanova M; Roumenina LT; Vasilev V
Methods Mol Biol; 2021; 2227():133-139. PubMed ID: 33847938
[TBL] [Abstract][Full Text] [Related]
12. Correlation between serum anti-C1q antibody levels and renal pathological characteristics and prognostic significance of anti-C1q antibody in lupus nephritis.
Cai X; Yang X; Lian F; Lin X; Liang M; Li J; Chen X; Liang L; Qin S; Fu J
J Rheumatol; 2010 Apr; 37(4):759-65. PubMed ID: 20194446
[TBL] [Abstract][Full Text] [Related]
13. [The roles of complement 1q and anti-C1q autoantibodies in pathogenesis of lupus nephritis].
Zhang FC; Zhou B; Dong Y
Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(14):955-9. PubMed ID: 16061001
[TBL] [Abstract][Full Text] [Related]
14. Predictive value of IgG autoantibodies against C1q for nephritis in systemic lupus erythematosus.
Siegert CE; Daha MR; Tseng CM; Coremans IE; van Es LA; Breedveld FC
Ann Rheum Dis; 1993 Dec; 52(12):851-6. PubMed ID: 8311534
[TBL] [Abstract][Full Text] [Related]
15. Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus.
Marto N; Bertolaccini ML; Calabuig E; Hughes GR; Khamashta MA
Ann Rheum Dis; 2005 Mar; 64(3):444-8. PubMed ID: 15286009
[TBL] [Abstract][Full Text] [Related]
16. Anti-C1q antibody in patients with lupus nephritic flare: 18-month follow-up and a nested case-control study.
Fatemi A; Samadi G; Sayedbonakdar Z; Smiley A
Mod Rheumatol; 2016; 26(2):233-9. PubMed ID: 26357965
[TBL] [Abstract][Full Text] [Related]
17. Anti-C1q autoantibodies in lupus nephritis.
Sinico RA; Rimoldi L; Radice A; Bianchi L; Gallelli B; Moroni G
Ann N Y Acad Sci; 2009 Sep; 1173():47-51. PubMed ID: 19758131
[TBL] [Abstract][Full Text] [Related]
18. Anti-C1q antibodies may help in diagnosing a renal flare in lupus nephritis.
Moroni G; Trendelenburg M; Del Papa N; Quaglini S; Raschi E; Panzeri P; Testoni C; Tincani A; Banfi G; Balestrieri G; Schifferli JA; Meroni PL; Ponticelli C
Am J Kidney Dis; 2001 Mar; 37(3):490-8. PubMed ID: 11228172
[TBL] [Abstract][Full Text] [Related]
19. Association between ongoing anti-C1q antibody production in peripheral blood and proliferative nephritis in patients with active systemic lupus erythematosus.
Gunnarsson I; Rönnelid J; Huang YH; Rogberg S; Nilsson B; Lundberg I; Klareskog L
Br J Rheumatol; 1997 Jan; 36(1):32-7. PubMed ID: 9117171
[TBL] [Abstract][Full Text] [Related]
20. Correlation between the renal C1q deposition and serum anti-C1q antibody: a potential role of anti-C1q antibody in lupus nephritis.
Chen PC; Wang CR; Liu MF; Chen FF; Liang CC
Asian Pac J Allergy Immunol; 2002 Dec; 20(4):223-7. PubMed ID: 12744622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
